Use of NSAIDS and COX-2 inhibitors in osteoarthritis patients in Europe and the USA

被引：0
|
作者：
Piercy, J
Turner, A
Hird, A
Karavali, M
机构：
[1] Adelphi Grp Prod, Macclesfield, Cheshire, England
[2] Thames Valley Univ, London, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [31] The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis
    Kamath, CC
    Kremers, HM
    Vanness, DJ
    O'Fallon, WM
    Cabanela, RL
    Gabriel, SE
    VALUE IN HEALTH, 2003, 6 (02) : 144 - 157
  • [32] Risk of Nonunion with Nonselective NSAIDs, COX-2 Inhibitors, and Opioids
    George, Michael D.
    Baker, Joshua F.
    Leonard, Charles E.
    Mehta, Samir
    Miano, Todd A.
    Hennessy, Sean
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2020, 102 (14): : 1230 - 1238
  • [33] Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam
    Curtiss, FR
    JOURNAL OF MANAGED CARE PHARMACY, 2006, 12 (03): : 265 - 268
  • [34] The brand new selective COX-2 inhibitors NSAIDs.
    Cano, DL
    Rodríguez, BG
    Domínguez, YT
    Delgado, PH
    Esteban, JMH
    Gutiérrez, JMH
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1999, 91 (08) : 598 - 598
  • [35] Selective COX-2 inhibitors, NSAIDs, aspirin, myocardial infarction
    Dalen, JE
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) : 1091 - 1092
  • [36] Postoperative NSAIDs and COX-2 inhibitors: cardiovascular risks and benefits
    Jones, SF
    Power, I
    BRITISH JOURNAL OF ANAESTHESIA, 2005, 95 (03) : 281 - 284
  • [37] COX-2 inhibitors and other NSAIDs linked to MI hospitalisation
    Reactions Weekly, 2005, 1059 (1) : 4 - 4
  • [38] COX-2 specific inhibitors: Are NSAIDs and the stomach become reconciled?
    Bannwarth, B
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2001, 25 (04): : B79 - B84
  • [39] Gastrointestinal safety of NSAIDs versus COX-2 inhibitors - Reply
    Drenth, Joost P. H.
    van Oijen, Martijn G. H.
    Verheugt, Freek W. A.
    LANCET, 2007, 369 (9570): : 1345 - 1345
  • [40] Value of Information in the Osteoarthritis Setting Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
    Latimer, Nicholas
    Lord, Joanne
    Grant, Robert L.
    O'Mahony, Rachel
    Dickson, John
    Conaghan, Philip G.
    PHARMACOECONOMICS, 2011, 29 (03) : 225 - 237
12345